Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan Medical Device Investing
European Commission Approves RINVOQ® as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis Biotech Investing
Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis Biotech Investing
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older Pharmaceutical Investing
Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board Cannabis Investing News
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021 Biotech Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Orencia for the Prevention of Acute Graft Versus Host Disease Biotech Investing
XELJANZ® Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis Pharmaceutical Investing
U.S. Food and Drug Administration Approves Opdivo® for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma Biotech Investing
Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 Medical Device Investing
